A detailed comparison of SGLT2 Inhibitors (Class Overview) and GLP-1 Receptor Agonists (Class Overview) to help you understand the differences and make informed decisions about your diabetes treatment.
SGLT2 Inhibitors
GLP-1 Receptor Agonists
SGLT2 Inhibitors (Class Overview) may cause: Increased urination (especially when starting), Yeast infections, Urinary tract infections. GLP-1 Receptor Agonists (Class Overview) may cause: Nausea (especially when starting), Feeling full or bloated, Constipation or diarrhea.
This comparison is for educational purposes. Only your healthcare provider can determine which medication is right for you.
Browse All Medications